GlassScriptPhysician profile
Joshua Gerard Karlin
NPI 1730594953
$14,255.98
in general payments reported to CMS, 2019-2025
20 companies · $3,369 in 2025
The $3,369 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $672 · 2021: $2,009 · 2022: $3,365 · 2023: $3,324 · 2024: $464 · 2025: $3,369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,276 · Food and Beverage: $2,881.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,276.24 |
| Food and Beverage | $2,881.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $7,971.54 | 2021-2025 | Excelsiusgps Robotic Navigation System, Xlif, Excelsius Gps |
| Cerapedics INC. | $3,554.56 | 2023-2025 | I-Factor Peptide Enhanced Bone Graft |
| Elite Orthopedics, LLC | $780.00 | 2019 | |
| Stryker Corporation | $683.92 | 2019-2021 | |
| Medical Device Business Services, INC. | $319.98 | 2020 | |
| Medtronic, INC. | $208.86 | 2022-2023 | Unid_pass |
| Next Science LLC | $160.27 | 2024 | Xperience, Blastx, Surgx |
| Spinal Elements, INC. | $115.83 | 2021 | |
| Orthofix Medical, INC. | $92.25 | 2023-2024 | Forza, M6-C, Cervical-Stim |
| Centinel Spine, LLC | $88.19 | 2025 | Prodisc L |
| Zimmer Biomet Holdings, INC. | $79.64 | 2019 | |
| Viiv Healthcare Company | $46.44 | 2024-2025 | Dovato |
| Carlsmed, INC. | $36.99 | 2025 | Aprevo |
| Genzyme Corporation | $30.62 | 2025 | |
| Si-Bone, INC. | $26.85 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Melinta Therapeutics, LLC | $14.91 | 2025 | Rezzayo, Kimyrsa |
| Depuy Synthes Sales INC. | $14.89 | 2020 | |
| Theragen, INC. | $14.00 | 2025 | Actastim-S |
| Kuros Biosciences USA, INC | $13.30 | 2022 | |
| Ulrich Medical USA, INC. | $2.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Karlin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.